Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity

NCT ID: NCT02945410

Last Updated: 2019-12-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if an increased protein intake can attenuate the suppression of metabolic and anabolic hormones during caloric restriction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Preliminary testing

Prior to the study start, participants will be weighed and body composition will be determined using calipermetry (7 sites) and bioelectrical impedance. Peak oxygen uptake (VO2peak) will be assessed using an incremental exercise test on a bicycle ergometer.
2. Randomization

Participants will proceed through each of the following conditions lasting 5 days:

CR-LP: Participants will be restricted to 30 kcal/kg FFM/day and protein intake will be low (0.8 g/kg BW/day).

CR-HP: Participants will be restricted to 30 kcal/kg FFM/day and protein intake will be high (1.7 g/kg BW/day).

CON: Participants will be in energy balance and consume 1.7 g protein/kg BW/day.
3. Diet Prescription

Dietary energy intake will be controlled using clinical products and maltodextrin to meet target energy intakes. Participants will received calcium and Vitamin D supplementation throughout the study.
4. Exercise Prescription

During all conditions, participants will conduct daily supervised exercise on a bicycle ergometer at an exercise intensity of 60% VO2peak. Exercise duration will be adjusted individually such that exercise energy expenditure will amount to 15 kcal/kg FFM/day. Additional exercise and intense physical activity will be prohibited.
5. Assessments

The following assessments will be conducted prior to the start of each condition as well as upon completion of each condition: body weight and composition (impedance), fasting blood draw for assessment of metabolic and anabolic hormones, resting metabolic rate, aerobic fitness (VO2peak), and questionnaires.
6. Washout

Once a participant has completed a study condition, participant will be allowed a washout of at least 14 days to allow protein balance to return to baseline (Hoffer \& Forse, 1990). During this time, participants will resume their regular diet and physical activity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Weight Loss Starvation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caloric Restriction and High Protein

Participants will be calorie restricted to 30 kcal/kg FFM/day and consume 1.7 g protein/kg BW/day.

Group Type EXPERIMENTAL

Caloric Restriction

Intervention Type OTHER

Participants will consume 30 kcal/kg FFM/day.

Protein

Intervention Type OTHER

Participants will consume 1.7 g protein/kg BW/day.

Exercise

Intervention Type OTHER

Participants will conduct aerobic exercise designed to expend 15 kcal/kg FFM/day

Calcium and Vitamin D

Intervention Type DIETARY_SUPPLEMENT

Participants will be provided calcium and vitamin D supplement in order to maintain calcium and Vitamin D intake constant across all study arms

Maltodextrin

Intervention Type OTHER

Participants will be provided with maltodextrin to supplement the liquid diet in order to meet caloric needs within each study arm

Caloric Restriction and Normal Protein

Participants will be calorie restricted to 30 kcal/kg FFM/day and consume 0.8 g protein/kg BW/day.

Group Type ACTIVE_COMPARATOR

Caloric Restriction

Intervention Type OTHER

Participants will consume 30 kcal/kg FFM/day.

Exercise

Intervention Type OTHER

Participants will conduct aerobic exercise designed to expend 15 kcal/kg FFM/day

Calcium and Vitamin D

Intervention Type DIETARY_SUPPLEMENT

Participants will be provided calcium and vitamin D supplement in order to maintain calcium and Vitamin D intake constant across all study arms

Maltodextrin

Intervention Type OTHER

Participants will be provided with maltodextrin to supplement the liquid diet in order to meet caloric needs within each study arm

Energy Balance

Participants will be in energy balance and consume 1.7 g protein/kg BW/day.

Group Type PLACEBO_COMPARATOR

Protein

Intervention Type OTHER

Participants will consume 1.7 g protein/kg BW/day.

Exercise

Intervention Type OTHER

Participants will conduct aerobic exercise designed to expend 15 kcal/kg FFM/day

Calcium and Vitamin D

Intervention Type DIETARY_SUPPLEMENT

Participants will be provided calcium and vitamin D supplement in order to maintain calcium and Vitamin D intake constant across all study arms

Maltodextrin

Intervention Type OTHER

Participants will be provided with maltodextrin to supplement the liquid diet in order to meet caloric needs within each study arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caloric Restriction

Participants will consume 30 kcal/kg FFM/day.

Intervention Type OTHER

Protein

Participants will consume 1.7 g protein/kg BW/day.

Intervention Type OTHER

Exercise

Participants will conduct aerobic exercise designed to expend 15 kcal/kg FFM/day

Intervention Type OTHER

Calcium and Vitamin D

Participants will be provided calcium and vitamin D supplement in order to maintain calcium and Vitamin D intake constant across all study arms

Intervention Type DIETARY_SUPPLEMENT

Maltodextrin

Participants will be provided with maltodextrin to supplement the liquid diet in order to meet caloric needs within each study arm

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 4 hours/week of purposeful aerobic exercise over the last 3 months
* Body mass index: 19-25 kg/m2
* \< 15% body fat

Exclusion Criteria

* Cardiovascular disease risk factors that would result in greater than low risk
* Smoking
* Type I, type II diabetes, or history of high fasting glucose;
* History of high blood pressure and/or use of medication for hypertension;
* History of Dyslipidemia, or on lipid-lowering medication;
* Underlying health condition and/or use of medication that could interfere with any of our study outcomes.
* History or current diagnosis of a clinical eating disorder
* Failure to adhere to study protocol
Minimum Eligible Age

19 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nebraska Lincoln

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karsten Koehler, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Nebraska Lincoln

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sports and Exercise Nutrition Laboratory, Department of Nutrition and Health Sciences, Ruth Leverton Hall

Lincoln, Nebraska, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006 Dec;27(7):750-61. doi: 10.1210/er.2006-0032. Epub 2006 Nov 22.

Reference Type BACKGROUND
PMID: 17122359 (View on PubMed)

Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009 Feb;41(2):459-71. doi: 10.1249/MSS.0b013e3181949333.

Reference Type BACKGROUND
PMID: 19127177 (View on PubMed)

Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010 Jul;68(7):375-88. doi: 10.1111/j.1753-4887.2010.00298.x.

Reference Type BACKGROUND
PMID: 20591106 (View on PubMed)

Forbes GB. Body fat content influences the body composition response to nutrition and exercise. Ann N Y Acad Sci. 2000 May;904:359-65. doi: 10.1111/j.1749-6632.2000.tb06482.x.

Reference Type BACKGROUND
PMID: 10865771 (View on PubMed)

Areta JL, Burke LM, Camera DM, West DW, Crawshay S, Moore DR, Stellingwerff T, Phillips SM, Hawley JA, Coffey VG. Reduced resting skeletal muscle protein synthesis is rescued by resistance exercise and protein ingestion following short-term energy deficit. Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E989-97. doi: 10.1152/ajpendo.00590.2013. Epub 2014 Mar 4.

Reference Type BACKGROUND
PMID: 24595305 (View on PubMed)

Carbone JW, Pasiakos SM, Vislocky LM, Anderson JM, Rodriguez NR. Effects of short-term energy deficit on muscle protein breakdown and intramuscular proteolysis in normal-weight young adults. Appl Physiol Nutr Metab. 2014 Aug;39(8):960-8. doi: 10.1139/apnm-2013-0433. Epub 2014 Jun 19.

Reference Type BACKGROUND
PMID: 24945715 (View on PubMed)

Wasserman DH, Kang L, Ayala JE, Fueger PT, Lee-Young RS. The physiological regulation of glucose flux into muscle in vivo. J Exp Biol. 2011 Jan 15;214(Pt 2):254-62. doi: 10.1242/jeb.048041.

Reference Type BACKGROUND
PMID: 21177945 (View on PubMed)

Gault ML, Willems ME. Aging, functional capacity and eccentric exercise training. Aging Dis. 2013 Sep 25;4(6):351-63. doi: 10.14336/AD.2013.0400351.

Reference Type BACKGROUND
PMID: 24307968 (View on PubMed)

Dulloo AG, Jacquet J, Montani JP, Schutz Y. How dieting makes the lean fatter: from a perspective of body composition autoregulation through adipostats and proteinstats awaiting discovery. Obes Rev. 2015 Feb;16 Suppl 1:25-35. doi: 10.1111/obr.12253.

Reference Type BACKGROUND
PMID: 25614201 (View on PubMed)

Wade GN, Schneider JE, Li HY. Control of fertility by metabolic cues. Am J Physiol. 1996 Jan;270(1 Pt 1):E1-19. doi: 10.1152/ajpendo.1996.270.1.E1.

Reference Type BACKGROUND
PMID: 8772468 (View on PubMed)

Loucks AB. Energy balance and body composition in sports and exercise. J Sports Sci. 2004 Jan;22(1):1-14. doi: 10.1080/0264041031000140518.

Reference Type BACKGROUND
PMID: 14974441 (View on PubMed)

Misra M, Klibanski A. The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology. 2011;93(2):65-73. doi: 10.1159/000323771. Epub 2011 Jan 13.

Reference Type BACKGROUND
PMID: 21228564 (View on PubMed)

Ihle R, Loucks AB. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res. 2004 Aug;19(8):1231-40. doi: 10.1359/JBMR.040410. Epub 2004 Apr 19.

Reference Type BACKGROUND
PMID: 15231009 (View on PubMed)

De Souza MJ, Williams NI. Beyond hypoestrogenism in amenorrheic athletes: energy deficiency as a contributing factor for bone loss. Curr Sports Med Rep. 2005 Feb;4(1):38-44. doi: 10.1007/s11932-005-0029-1.

Reference Type BACKGROUND
PMID: 15659278 (View on PubMed)

Rizzoli R, Bianchi ML, Garabedian M, McKay HA, Moreno LA. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone. 2010 Feb;46(2):294-305. doi: 10.1016/j.bone.2009.10.005. Epub 2009 Oct 17.

Reference Type BACKGROUND
PMID: 19840876 (View on PubMed)

Pikosky MA, Smith TJ, Grediagin A, Castaneda-Sceppa C, Byerley L, Glickman EL, Young AJ. Increased protein maintains nitrogen balance during exercise-induced energy deficit. Med Sci Sports Exerc. 2008 Mar;40(3):505-12. doi: 10.1249/MSS.0b013e31815f6643.

Reference Type BACKGROUND
PMID: 18379214 (View on PubMed)

Pasiakos SM, Margolis LM, McClung JP, Cao JJ, Whigham LD, Combs GF, Young AJ. Whole-body protein turnover response to short-term high-protein diets during weight loss: a randomized controlled trial. Int J Obes (Lond). 2014 Jul;38(7):1015-8. doi: 10.1038/ijo.2013.197. Epub 2013 Oct 29.

Reference Type BACKGROUND
PMID: 24166063 (View on PubMed)

Chevalley T, Bonjour JP, Ferrari S, Rizzoli R. High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys. J Bone Miner Res. 2008 Jan;23(1):131-42. doi: 10.1359/jbmr.070907.

Reference Type BACKGROUND
PMID: 17892378 (View on PubMed)

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704. Epub 2010 Nov 29.

Reference Type BACKGROUND
PMID: 21118827 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15895

Identifier Type: -

Identifier Source: org_study_id